Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    • News

    Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times

    Perhaps the displeasure of waiting in line for hours to get a COVID test this holiday season would be slightly allayed if you were a shareholder in a pathology company doing the leg work? Investors who saw the value in pathology and ‘pro-pandemic’ stocks like Australian Clinical Labs (ASX: ACL) will be glad to read

    Read More
    Public
  • Queensland Revenue Office engages SenSen for mobile number plate scanning
    • News

    Queensland Revenue Office engages SenSen for mobile number plate scanning

    Work smarter, not harder. That’s exactly what the Queensland State Revenue Office is going to do going forward as the State increases its smart city capabilities, having engaged tech company SenSen Networks (ASX: SNS) for mobile number plate scanning. The engagement will be for 3 years and is valued at a minimum of $192,000 to

    Read More
    Public
  • Shareholders back Pharmaxis liver cancer treatment trials via oversubscribed capital raise
    • News

    Shareholders back Pharmaxis liver cancer treatment trials via oversubscribed capital raise

    When the University of Rochester came knocking on the door of biopharmaceutical company Pharmaxis (ASX: PXS), it was a boost from a respected group of researchers for their lead drug candidate PXS-5505 which has continued to draw attention from around the world.  By agreement with Pharmaxis, the University of Rochester embarked on preclinical work on 

    Read More
    Public
  • Concussion tech company bringing product to grassroots athletes
    • News

    Concussion tech company bringing product to grassroots athletes

    Take it from me- concussions are awful. There’s unrelenting dizziness, nausea and that foggy brain feeling, if you’re lucky. Those who fare worse can be left with permanent issues with balance, mood, memory and cognition.  A major cause of concussion is sport, where concussion management technology company HITIQ (ASX: HIQ) is working to reduce its

    Read More
    Public
  • Lumos receives first orders from Canada for rapid COVID test kits following regulatory approval
    • News

    Lumos receives first orders from Canada for rapid COVID test kits following regulatory approval

    Having secured approval from regulators in Canada last month, Lumos Diagnostics (ASX: LDX) is set to dispatch the first orders of their rapid antigen test kit to the Maple nation with the initial orders valued at USD $250,000 (AUD $350,000).  The orders are for Lumos’ CoviDx™ test kit which will enable qualified healthcare providers to

    Read More
    Public
  • Crowd Media to target the Metaverse with their digital avatar platform
    • News

    Crowd Media to target the Metaverse with their digital avatar platform

    If the artificial intelligence technology being developed by Crowd Media (ASX: CM8) reaches its full potential, there is a pretty good chance you’ll be using it in everyday life for things like banking or doctors appointments. But what may be even more impressive, is that you could be doing it in the Metaverse rather than

    Read More
    Public
  • «
  • ‹
  • 427
  • 428
  • 429
  • 430
  • 431
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.